Point72's new $22.3M position is notable but represents a hedge fund making a high-conviction debut, while passive trimming suggests no broad re-rating catalyst. Given IVVD's $265M market cap and 89% analyst bullish consensus, the cluster is directionally supportive but not transformative. Monitor upcoming pipeline catalysts (PEMGARDA variant neutralization data, cash runway disclosures) for follow-through; history warns against overweighting this signal alone.
IVVD drugs
IVVD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $0.8125entry
- T+1 · 5mo ago −5.23%α −5.77% · $0.7700
- T+5 · 5mo ago +14.61%α +14.18% · $0.9312
- T+20 · 4mo ago −1.08%α −2.97% · $0.8037
- T+60 · 2mo ago +1.66%α −2.73% · $0.8260
How similar events traded
Executive Summary
In 2025-Q3, a mixed institutional cluster formed in IVVD: 6 buyers added $26.7M (dominated by Point72's new $22.3M position) while 3 passive sellers trimmed $975K. The cluster shows strong active-fund conviction offset by heavy passive selling, indicating divergent views on Invivyd's pipeline trajectory vs. cash-burn risks.
Key Financial Metrics
Institutional Positions
Net institutional flow: $26.7M
▲ Buyers (6)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Point72 | NEW | Not reported | $22.3M | $22.3M |
| Vanguard | ADD | +46.7% | $6.3M | $3.5M |
| Morgan Stanley | ADD | +51.9% | $858.0K | $491.0K |
| Two Sigma | ADD | +40.3% | $369.0K | $198.0K |
| Invesco | ADD | +28.1% | $193.0K | $95.0K |
| BofA | DOUBLED | +330.5% | $54.0K | $46.0K |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| BlackRock | TRIM | -57.4% | $1.2M | -$415.1K |
| UBS | NEAR_EXIT | -86.4% | $706.0K | -$559.0K |
| Wells Fargo | NEAR_EXIT | -87.7% | $1.0K | -$1.2K |
Key Facts
- 6 institutional buyers added $26.7M in aggregate new IVVD exposure in Q3 2025
- Point72 initiated a new $22.3M position (20.3M shares), the dominant active move
- 3 sellers (BlackRock, Wells Fargo, UBS) trimmed a combined $975K, mostly passive rebalancing
- Vanguard added +1.83M shares ($3.5M net), raising stake to 5.76M shares
- The cluster is 83% passive/index fund weight (5 of 9 funds), diluting signal strength
Financial Impact
6 buyers added $26.7M in IVVD equity (dominated by Point72's $22.3M new position); 3 sellers trimmed $975K. Net institutional inflow of ~$25.7M.
Risk Factors
- Cluster dominated by passive/index funds (5 of 9) reducing signal quality
- Point72 position may represent short-term hedged exposure rather than long fundamental conviction
- 13F 45-day lag, positions may have been adjusted since quarter-end
- Pre-revenue biotech with limited operating history; institutional conviction can reverse on clinical data
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-IVVD-2025-Q3 |
Track record
19 reports on IVVD
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +35.85% at T+20 after the Jul 6, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 6/10 Entry $0.5603 settles Nov 23
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $0.5815 to $0.5744 ▼ −1.22% −0.63% vs SPY
- Sep 29, 20266w ago 8-K Bullish 7/10 Entry $0.8501 to $0.8064 ▼ −5.14% −7.09% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $0.9640 to $0.8501 ▼ −11.82% −10.63% vs SPY
- Sep 1, 202610w ago 8-K Neutral 6/10 Entry $0.8800 to $0.7973 ▼ −9.40% −9.48% vs SPY
- Aug 17, 202613w ago 144 Neutral 2/10 Entry $0.8680 to $0.9387 ▲ +8.15% +8.35% vs SPY
- Jul 6, 202619w ago 8-K Bearish 6/10 Entry $0.8340 to $0.7834 ▲ +6.07% +6.56% vs SPY
- Jun 16, 202621w ago Press Release Neutral 5/10 Entry $0.8918 to $0.9346 ▲ +4.80% +7.03% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Viewing Entry $0.8125 to $0.9312 ▲ +14.61% +14.18% vs SPY
- Jun 9, 202622w ago Press Release Neutral 4/10 Entry $0.9900 to $0.8686 ▼ −12.26% −14.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers